The oral KIF11 inhibitor 4SC-205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
